Azelastine Hydrochloride
Product Images NDC 68071-2497

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Azelastine Hydrochloride (NDC 68071-2497). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2497 1)

Pdp (68071 2497 1)
Label of Azelastine Hydrochloride 1% nasal solution, 30 mL, distributed by NuCare Pharmaceuticals, Inc. The label includes dosing information specifying each spray delivers 0.137 mL (137 mcg as Azelastine Hydrochloride equivalent to 125 mcg of Azelastine base). It has manufacturer info from Apotex Inc., Toronto, Ontario, Canada. The label also features lot, expiration, and serial information.*
FDA Label Image

Figurea.jpg (Figurea)

Figurea.jpg (Figurea)
An instructional diagram labelled Figure A showing the assembly components of a nasal spray consisting of a cover, spray pump unit, clip, and bottle. The diagram illustrates how the parts fit together for Azelastine Hydrochloride nasal spray by NuCare Pharmaceuticals, Inc.*
FDA Label Image

Figureb.jpg (Figureb)

Figureb.jpg (Figureb)
An instructional diagram labeled 'Figure B' showing how to use a nasal spray bottle. The image depicts an arrow pointing upward from the spray applicator and another arrow pointing right indicating the removal or placement of a cap next to the bottle. The bottle is unbranded and the illustration is likely intended for user guidance with Azelastine Hydrochloride nasal spray.*
FDA Label Image

Figurec.jpg (Figurec)

Figurec.jpg (Figurec)
An illustration showing a hand holding a small bottle, pressing down on the top to spray a mist. This is a step in the administration or use of a nasal spray, likely for Azelastine Hydrochloride.*
FDA Label Image

Figured.jpg (Figured)

Figured.jpg (Figured)
An instructional illustration labeled Figure D shows a person administering a nasal spray by inserting the spray nozzle into one nostril while holding the spray bottle with their hand. The image demonstrates the proper technique for using a nasal spray product.*
FDA Label Image

Figuree.jpg (Figuree)

Figuree.jpg (Figuree)
An instructional illustration labeled Figure E showing a person with their eyes closed while using their index finger to press the side of their nose, presumably demonstrating how to properly administer a nasal spray.*
FDA Label Image

Figuref-and-g.jpg (Figuref And G)

Figuref-and-g.jpg (Figuref And G)
Instructional illustrations for Azelastine Hydrochloride nasal spray demonstrating proper use: Figure F shows a person twisting the spray bottle's nozzle, while Figure G depicts how to hold and spray the bottle, with droplets dispersing from the nozzle.*
FDA Label Image

Structure.jpg (Structure)

Structure.jpg (Structure)
Chemical structure of azelastine hydrochloride showing its molecular arrangement with chlorophenyl, benzazepine, and piperazine rings and hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.